News
News

The latest updates from AFAR.

Grantee in the News: Satchidananda Panda’s latest cancer research discovery in Nature

Jan 17
2018

Grantee in the News: Satchidananda Panda’s latest cancer research discovery in Nature

On January 10, 2018, Nature published research co-authored by 2014 Julie Martin Mid-Career Award in Aging Research recipient, Satchidananda Panda, Ph.D.   In “Pharmacological activation of REV-ERBs is lethal in cancer and oncogene- induced senescence,” Dr. Panda with other Salk Institute researchers discovered how to curb the growth of cancer cells by blocking the cells’ access to certain nutrients. In a related release, Panda states: "When we block access to these resources, cancer cells starve to death but normal cells are already used to this constraint so they're not affected.” The original research is available by…


View MoreREAD MORE


Board Member in the News: S. Jay Olshansky on Age, Health, and the Presidency in the Washington Examiner

Jan 10
2018

Board Member in the News: S. Jay Olshansky on Age, Health, and the Presidency in the Washington Examiner

On January 2, 2018, the Washington Examiner featured insights by AFAR Board Member and 2016 Irving S. Wright Award winner S. Jay Olshansky, Ph.D. in an article examining the increased interest in President Trump’s physical health. The article, "Trump’s medical exam will disappoint critics. Here’s why” notes: S. Jay Olshansky from the University of Illinois at Chicago, a leading researcher on aging, warned against drawing conclusions about people's expected lifespan just because of the way they eat, pointing to billionaire Warren Buffett, 87, who has a fast-food diet. "The science tells us there are some…


View MoreREAD MORE


Grantee in the News: Norman Sharpless on how big data will change cancer research in Science

Jan 9
2018

Grantee in the News: Norman Sharpless on how big data will change cancer research in Science

On December 21, 2017, Science Magazine interviewed Norman “Ned” Sharpless, M.D. on the future of cancer research.   Recently appointed the Director of the National Cancer Institute of the National Institute of Health, Dr. Norman Sharpless was a 2003 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar and also has served on AFAR’s National Scientific Advisory Council from 2005-2011. Dr. Sharpless chaired the Selection Committee of the Glenn/AFAR Postdoctoral Program for Transnational Research on Aging program in 2015 and 2016. Dr. Sharpless spoke about the future of cancer research in “New NCI director expects…


View MoreREAD MORE


Experts in the News: Barzilai, Campisi, and Lithgow featured in three-part BBC News Series on Aging

Dec 27
2017

Experts in the News: Barzilai, Campisi, and Lithgow featured in three-part BBC News Series on Aging

  Between December 18 and 20, 2017, BBC News featured three AFAR experts in a three-part series exploring breakthroughs in aging research: --Deputy Scientific Director and multiple grantee Nir Barzilai, MD --1990 Research Grant for Junior Faculty recipient Judith Campisi, PhD and -- 2006 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award recipient Gordon Lithgow, PhD Dr. Barzilai shares insights on the Targeting Aging with Metformin (TAME) trial in the article “Could drugs delay the diseases of ageing?” Dr. Campisi discusses a future of where we can live healthier as we grow older thanks to drug interventions in the article, “What are…


View MoreREAD MORE


Experts in the News: Anderson and de Cabo’s co-edit special journal on Caloric Restriction and Biology of Aging

Dec 27
2017

Experts in the News: Anderson and de Cabo’s co-edit special journal on Caloric Restriction and Biology of Aging

  The January 2018 issue of The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences  has been co-edited by 2016 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award winner Rozalyn Anderson, PhD, FGSA and 2014 Vincent Cristofalo Rising Star Award in Aging Research winner Rafael de Cabo, PhD. This issue also marks Dr. Anderson’s debut as co-editor-in-chief, in a related press release notes: "Remarkably, caloric restriction has been shown to be effective in delaying aging in multiple species and the results in humans look equally promising," Anderson said. "Indeed for many studies, CR is used as…


View MoreREAD MORE




BACK TO TOPBACK TO TOP